Ageing and multiple sclerosis
Neurologijos seminarai · 2024
DOI: 10.15388/ns.2024.28.100.2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neurologijos seminarai, 2024. Verfasst von Julija Isačenko und 1 weiteren Autor:innen. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Advances in the treatment of multiple sclerosis in recent decades have allowed an increasing number of people to reach advanced age without significant disability. Most disease-modifying drugs are designed to suppress active inflammation and reduce the risk of relapses; however, as patients age, the pathogenetic mechanisms of the disease change, and progression independent of relapse activity (PIRA) begins to prevail. The prolonged duration of drug-induced immunosuppression, combined with age-related comorbidities, may lead to adverse effects. In this article, we review age-related changes in multiple sclerosis pathogenesis and the associated treatment challenges.
Zitieren
APA
Isačenko, J., & Balnytė, R. (2024). Ageing and multiple sclerosis. Neurologijos seminarai. https://doi.org/10.15388/ns.2024.28.100.2
Vancouver
Isačenko J, Balnytė R. Ageing and multiple sclerosis. Neurologijos seminarai. 2024. doi:10.15388/ns.2024.28.100.2
BibTeX
@article{Isaenko2024,
author = {Isačenko, Julija and Balnytė, Renata},
title = {Ageing and multiple sclerosis},
journal = {Neurologijos seminarai},
year = {2024},
doi = {10.15388/ns.2024.28.100.2}
}
EUVIMED